US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
BI

BICO.ST

$20.60
Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.97%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

BICO Group AB (publ) (BICO.ST) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Price target
$29.00
+40.8% · 2 analysts
Institutional own.
24.2%
of shares
NON-COMPLIANT
Sharia compliance
0.97%
Non-permissible income — HTR, from filings (2025-12-31)
$29.00
Price target (+40.8%) · 2 analysts
24.2%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. BICO.ST files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 115.72% 30.00% Fail
Interest-bearing investments 88.35% 30.00% Fail
Non-permissible income 0.97% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 42.44% 33.00% Fail
Interest-bearing investments 32.40% 33.00% Pass
Non-liquid assets 57.41% at least 20.00% Pass
Non-permissible income 0.97% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 42.44% 33.33% Fail
Cash + interest-bearing securities 32.40% 33.33% Pass
Accounts receivable 42.59% 33.33% Fail
Non-permissible income 0.97% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 42.44% 33.33% Fail
Cash + interest-bearing securities 32.40% 33.33% Pass
Accounts receivable 42.59% 50.00% Pass
Non-permissible income 0.97% 5.00% Pass

Dow Jones Islamic Market Fail

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 87.47% 33.00% Fail
Cash + interest-bearing securities 66.78% 33.00% Fail
Accounts receivable 21.00% 33.00% Pass
Non-permissible income 0.97% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 72.22% 33.00% Fail
Cash + interest-bearing securities 55.14% 49.00% Fail
Accounts receivable 17.34% 49.00% Pass
Non-permissible income 0.97% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 72.22% 33.33% Fail
Cash + interest-bearing securities 55.14% 33.33% Fail
Accounts receivable 72.48% 49.00% Fail
Non-permissible income 0.97% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

23.9621.2218.4815.7413.002025-09-112026-03-122026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
19.92
S2
20.38
S1
20.72
PIVOT
21.18
R1
21.52
R2
21.98
R3
22.32

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
18.4501 24.1499
±13.38% from 21.3, made 2026-09-10 · resolves 2026-09-17
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21883 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
2 buy · 4 neutral · 1 sell
Moving averagesSTRONG BUY
10 buy · 0 neutral · 2 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)61.60NEUTRAL
Stochastic %K (14)48.94NEUTRAL
CCI (20)36.35NEUTRAL
Williams %R (14)-51.06NEUTRAL
MACD (12,26,9)-0.10SELL
ROC (10)3.52BUY
Momentum (10)0.70BUY
EMA (10)21.01SELL
SMA (10)21.46SELL
EMA (20)19.98BUY
SMA (20)19.91BUY
EMA (30)19.11BUY
SMA (30)18.41BUY
EMA (50)18.18BUY
SMA (50)16.72BUY
EMA (100)17.72BUY
SMA (100)17.44BUY
EMA (200)18.26BUY
SMA (200)17.81BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About BICO Group AB (publ)

Healthcare · Medical Devices

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables and applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics, such as genomics, as well as offers instruments and solutions for the manufacturing of diagnostics, as well as consumables. The Lab Automation segment provides the proprietary and hardware-agnostic Green Button Go Suite software for connected workflows, as well as automation technology integration, and consulting and engineering services to design, build, and install automated laboratory systems. In addition, the company offers a range of services and consumables such as reagents, bioinks, plates, and tissue models. It serves pharma and biopharma, biotech, diagnostics, academia and research, and cosmetic industries. The company offers its products through sales organizations, as well as through distributor network. BICO Group AB (publ) was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. The company was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

bico.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.